Supraventricular Tachycardia in Children
Igor A. Kovalev,
Igor A. Khamnagadaev,
Lilia I. Svintsova,
Tatiana K. Kruchina,
Dinara I. Sadykova,
Dina R. Sabirova,
Zulfiya R. Khabibrakhmanova,
Maria A. Shkolnikova https://doi.org/10.15690/pf.v16i3.2024
Abstract
Rhythm and conduction disorders of the heart occupy one of the leading places in the structure of cardiovascular pathology in children. Supraventricular tachycardias means tachyarrhythmias, caused by abnormal myocardial excitation with the source of rhythm localization above the His bundle bifurcation — in the atria, atrioventricular junction (node), and also arrhythmias with circulation of the excitation wave between the atria and the ventricles with additional atrial compounds. The team of authors presents clinical recommendations developed on the principles of evidence-based medicine, including all stages of diagnosis and treatment of children with supraventricular tachycardias. The use of recommendations in clinical practice allows to selecte the best strategy for diagnosis and treatment of supraventricular tachycardia in a particular patient.
Supporting agencies: Not specified
About the Authors
Igor A. Kovalev
Veltischev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
Igor A. Khamnagadaev
Veltischev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
Lilia I. Svintsova
Cardiology Research Institute Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Tatiana K. Kruchina
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Dinara I. Sadykova
Kazan State Medical University
Russian Federation
Russian Federation
Dina R. Sabirova
Kazan State Medical University
Russian Federation
Russian Federation
Zulfiya R. Khabibrakhmanova
Kazan State Medical University
Russian Federation
Russian Federation
Maria A. Shkolnikova
Veltischev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
References
1. Ko JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69(12):1028-1032. doi: 10.1016/0002-9149(92)90858-v.
2. Moak JP Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol. 2000;11(1):25-38. doi: 10.1016/s1058-9813(00)00033-3.
3. Practical management of pediatric cardiac arrhythmias. Ed by VL Zeigler, PC Gillette. New York, Futura Publishing Company, Inc.; 2001. 422 p.
4. Seslar SP, Garrison MM, Larison C, Salerno JC. A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborn and infants. Pediatr Cardiol. 2013;34(2):408-414. doi: 10.1007/s00246-012-0474-6.
5. Cardiac arrhythmias: their mechanisms, diagnosis, and management. Ed by WJ Mandel. Vol. 2. Transl. from English. Moscow: Meditsina; 1996. 206 p. (In Russ).
6. Quattrocelli A, Lang J, Davis A, Pflaumer A. Age makes a difference: symptoms in pediatric supraventricular tachycardia. J Arrhythm. 2018;34(5):565-571. doi: 10.1002/joa3.12103.
7. Baksiene ND, Sileikiene R, Sileikis V, et al. Atrial tachyarrhythmias in infants. Turk J Pediatr. 2008;50(2):143-148.
8. Skudarnova IM, Soboleva NV, Mychka NV. Gormony shchitovidnoj zhelezy: posobie dlya vrachej. Kol'tsovo: ZAO «Vektor-Best»; 2006. 32 р. (In Russ).
9. Tracy CM, Akhtar M, DiMarco JP et al. American College of Cardiology/American Heart Association clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. A report of the American College of Cardiology/ American Heart Association / American College of Physicians — American Society of Internal Medicine Task Force on clinical competence. J Am Coll Cardiol. 2000;36(5):1725-1736. doi: 10.1016/s0735-1097(00)01085-8.
10. Akdeniz C, Ergul Y, Kiplapinar N, Tuzcu V. Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants. Cardiol J. 2013;20(3):241-246. doi: 10.5603/CJ.2013.0068.
11. Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337-1382. doi: 10.1093/europace/eut082.
12. Rodriguez LM, de Chillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70(13):1213-1215. doi: 10.1016/0002-9149(92)90060-c.
13. Rekomendatsii po provedeniyu reanimatsionnykh meropriyatij Evropejskogo soveta po reanimatsii (peresmotr 2015 g.). Nats. sovet po reanimatsii; ed by VV Moroz; translated from English AA Mitrokhin. 3rd ed. revised and updated. Moscow: NIIOR NSR; 2016. 191 p. (In Russ).
14. Giglia TM, Massicotte MR Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128(24):2622-2703. doi: 10.1161/01.cir.0000436140.77832.7a.
15. Kruchina TK, Vasichkina YS, Novik GA, Egorov DF. Wolff-Parkinson-White syndrome in children: clinical course, diagnostics, treatment. Pediatricheskaya farmakologiya. 2011;8(5):49-53. (In Russ).
16. Blaufox AD. Cateter ablation of tachyarrhythmias in small children. Indian Pacing Electrophysiol J. 2005;5(1):51-62.
17. Saul RJ, Kanter RJ; Writing Committee, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm. 2016;13(6):e251-289. doi: 10.1016/j.hrthm.2016.02.009.
18. Svintsova LI, Popov SV, Kovalev IA. Radiofrequency ablation of drug-refractory arrhythmias in small children younger than 1 year of age: single-center experience. Pediatr Cardiol. 2013;34(6):1321-1329. doi: 10.1007/s00246-013-0643-2.
19. Pelliccia A, Fagard R, Bj0rnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422-1445. doi: 10.1093/eurheartj/ehi325.
20. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2343-2349. doi: 10.1016/j.jacc.2015.09.032.
21. Ko J. Left ventricular dysfunction and dilated cardiomyopathy in infants and children with wolff-Parkinson-white syndrome in the absence of tachyarrhythmias. Korean Circ J. 2012;42(12):803-808. doi: 10.4070/kcj.2012.42.12.803.
22. Fazio G, Mongiovi' M, Sutera L, et al. Segmental dyskinesia in Wolff-Parkinson-White syndrome: a possible cause of dilatative cardiomyopathy. Int J Cardiol. 2008;123(2):e31-34. doi: 10.1016/j.ijcard.2006.11.109.
23. Martsinkevich GI, Sokolov AA, Kovalev IA, et al. Elektromekhanicheskoe sopryazhenie miokarda v norme i u detei s sindromom WPW. Journal of arrhythmology. 2004;(35):38-44. (In Russ).
24. Khamnagadaev IA, Shkolnikova MA, Kokov LS, et al. Diastolic function of the right ventricle in patients with both manifesting syndrome and electrocardiographic phenomenon of Wolff-Parkinson-White. Journal of arrhythmology. 2012;(68):21-27. (In Russ).
Review
For citations:
Kovalev I.A., Khamnagadaev I.A., Svintsova L.I., Kruchina T.K., Sadykova D.I., Sabirova D.R., Khabibrakhmanova Z.R., Shkolnikova M.A. Supraventricular Tachycardia in Children. Pediatric pharmacology. 2019;16(3):133-143. (In Russ.) https://doi.org/10.15690/pf.v16i3.2024
Views:
1818
Email this article 